Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: May 21, 2022

Details for New Drug Application (NDA): 208223

✉ Email this page to a colleague

« Back to Dashboard

NDA 208223 describes ZEMBRACE SYMTOUCH, which is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the ZEMBRACE SYMTOUCH profile page.

The generic ingredient in ZEMBRACE SYMTOUCH is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 208223
Applicant:Upsher Smith Labs
Ingredient:sumatriptan succinate
Formulation / Manufacturing:see details
Pharmacology for NDA: 208223
Suppliers and Packaging for NDA: 208223
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZEMBRACE SYMTOUCH sumatriptan succinate SOLUTION;SUBCUTANEOUS 208223 NDA Upsher-Smith laboratories, LLC 0245-0809 0245-0809-38 4 SYRINGE in 1 CARTON (0245-0809-38) > 1 INJECTION, SOLUTION in 1 SYRINGE (0245-0809-89)
ZEMBRACE SYMTOUCH sumatriptan succinate SOLUTION;SUBCUTANEOUS 208223 NDA Promius Pharma, LLC 67857-809 67857-809-38 4 SYRINGE in 1 CARTON (67857-809-38) > 1 INJECTION, SOLUTION in 1 SYRINGE (67857-809-37)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;SUBCUTANEOUSStrengthEQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)
Approval Date:Jan 28, 2016TE:RLD:Yes
Patent:See Plans and PricingPatent Expiration:Jan 29, 2036Product Flag?Substance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.